Oncolytic adenovirus expressing bispecific antibody targets T‐cell cytotoxicity in cancer biopsies

JD Freedman, J Hagel, EM Scott, I Psallidas… - EMBO molecular …, 2017 - embopress.org
Oncolytic viruses exploit the cancer cell phenotype to complete their lytic life cycle, releasing
progeny virus to infect nearby cells and repeat the process. We modified the oncolytic group …
被引用次数：133 相关文章
[PDF] academia.edu

[PDF][PDF] Oncolytic adenovirus expressing bispecific antibody targets T-cell cytotoxicity in cancer biopsies

JD Freedman, J Hagel, EM Scott, I Psallidas, A Gupta… - 2017 - academia.edu
Oncolytic viruses exploit the cancer cell phenotype to complete their lytic life cycle, releasing
progeny virus to infect nearby cells and repeat the process. We modified the oncolytic group …
[PDF] researchgate.net

[PDF][PDF] Oncolytic adenovirus expressing bispecific antibody targets T-cell cytotoxicity in cancer biopsies

J Freedman, J Hagel, EM Scott, I Psallidas, A Gupta… - researchgate.net
Oncolytic adenovirus expressing bispecific antibody targets T‐cell cytotoxicity in cancer
biopsies Page 1 EMBO Molecular Medicine Peer Review Process File - EMM-2017-07567 © …

Oncolytic adenovirus expressing bispecific antibody targets T-cell cytotoxicity in cancer biopsies

JD Freedman, J Hagel, EM Scott… - EMBO molecular …, 2017 - pubmed.ncbi.nlm.nih.gov
Oncolytic viruses exploit the cancer cell phenotype to complete their lytic life cycle, releasing
progeny virus to infect nearby cells and repeat the process. We modified the oncolytic group …
[HTML] embopress.org

[HTML][HTML] Oncolytic adenovirus expressing bispecific antibody targets T‐cell cytotoxicity in cancer biopsies

JD Freedman, J Hagel, EM Scott, I Psallidas… - EMBO Molecular …, 2017 - embopress.org
Oncolytic viruses exploit the cancer cell phenotype to complete their lytic life cycle, releasing
progeny virus to infect nearby cells and repeat the process. We modified the oncolytic group …

Oncolytic adenovirus expressing bispecific antibody targets T‐cell cytotoxicity in cancer biopsies

J Freedman, J Hagel, E Scott, I Psallidas… - EMBO Molecular …, 2017 - ora.ox.ac.uk
Oncolytic viruses exploit the cancer cell phenotype to complete their lytic life cycle, releasing
progeny virus to infect nearby cells and repeat the process. We modified the oncolytic group …

Oncolytic adenovirus expressing bispecific antibody targets T‐cell cytotoxicity in cancer biopsies

JD Freedman, J Hagel, EM Scott… - EMBO Molecular …, 2017 - search.proquest.com
Oncolytic viruses exploit the cancer cell phenotype to complete their lytic life cycle, releasing
progeny virus to infect nearby cells and repeat the process. We modified the oncolytic group …

Oncolytic adenovirus expressing bispecific antibody targets T-cell cytotoxicity in cancer biopsies.

JD Freedman, J Hagel, EM Scott, I Psallidas… - EMBO Molecular …, 2017 - europepmc.org
Oncolytic viruses exploit the cancer cell phenotype to complete their lytic life cycle, releasing
progeny virus to infect nearby cells and repeat the process. We modified the oncolytic group …
[HTML] nih.gov

[HTML][HTML] Oncolytic adenovirus expressing bispecific antibody targets T‐cell cytotoxicity in cancer biopsies

JD Freedman, J Hagel, EM Scott… - EMBO Molecular …, 2017 - ncbi.nlm.nih.gov
Oncolytic viruses exploit the cancer cell phenotype to complete their lytic life cycle, releasing
progeny virus to infect nearby cells and repeat the process. We modified the oncolytic group …

Oncolytic adenovirus expressing bispecific antibody targets T‐cell cytotoxicity in cancer biopsies

JD Freedman, J Hagel, EM Scott, I Psallidas… - EMBO Molecular …, 2017 - embopress.org
Oncolytic viruses exploit the cancer cell phenotype to complete their lytic life cycle, releasing
progeny virus to infect nearby cells and repeat the process. We modified the oncolytic group …